COST-EFFECTIVENESS ANALYSIS OF CELL-BASED THERAPY FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

被引：0
|
作者：
Aballea, S. [1 ]
Karwala, P. [2 ]
Zerda, I [2 ]
Toumi, M. [3 ]
Pochopien, M. [2 ]
Han, R. [4 ]
Borissov, B. [5 ]
Clay, E. [4 ]
机构：
[1] Creat Ceut, Rotterdam, Netherlands
[2] Creat Ceut, Krakow, Poland
[3] Aix Marseille Univ, Marseille, France
[4] Creat Ceut, Paris, France
[5] Med Univ Sofia, Fac Publ Hlth, Dept Hlth Technol Assessment, Sofia, Bulgaria
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE283
引用
收藏
页码：S389 / S389
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease
    Gruneau, Lina
    Kechagias, Stergios
    Sandstrom, Per
    Ekstedt, Mattias
    Henriksson, Martin
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (07)
  • [2] COST-EFFECTIVENESS ANALYSIS OF NONINVASIVE SCORES FOR THE SCREENING OF NON-ALCOHOLIC FATTY LIVER DISEASE AMONG METABOLIC SYNDROME PATIENTS
    Phisalprapa, P.
    Kositamongkol, C.
    Saokaew, S.
    Chaiyakunapruk, N.
    VALUE IN HEALTH, 2019, 22 : S582 - S582
  • [3] Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease
    Vakhrushev, Ya M.
    Suchkova, E., V
    Lukashevich, A. P.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (02) : 29 - 33
  • [4] Non-alcoholic fatty liver disease screening in type 2 diabetes mellitus: A cost-effectiveness and price threshold analysis
    Choo, Bryan Peide
    Goh, George Boon -Bee
    Chia, Sing Yi
    Oh, Hong Choon
    Tan, Ngiap Chuan
    Tan, Jessica Yi Lyn
    Ang, Tiing Leong
    Bee, Yong Mong
    Wong, Yu Jun
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2022, 51 (11) : 686 - 694
  • [5] Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease
    Korkida, Foteini
    Stamatopoulou, Alexandra
    Roubelakis, Maria G.
    STEM CELLS TRANSLATIONAL MEDICINE, 2024, 13 (02) : 107 - 115
  • [6] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [7] Future therapy for non-alcoholic fatty liver disease
    Issa, Danny
    Patel, Vaishali
    Sanyal, Arun J.
    LIVER INTERNATIONAL, 2018, 38 : 56 - 63
  • [8] DIET THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
    Topilskaya, N.
    Isakov, V.
    Kaganov, B.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S522 - S522
  • [9] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) SCREENING IN HIGH-RISK POPULATION: A COST-EFFECTIVENESS AND PRICE-THRESHOLD ANALYSIS
    Choo, Bryan
    Goh, George B.
    Chia, Sing Yi
    Oh, Hong Choon
    Tan, Ngiap Chuan
    Tan, Jessica
    Ang, Tiing Leong
    Bee, Yong Mong
    Wong, Yu Jun
    GASTROENTEROLOGY, 2022, 162 (07) : S1134 - S1134
  • [10] Moexipril in patients with non-alcoholic fatty liver disease
    Silveira, Marina G.
    Talwalkar, Jay A.
    Lindor, Keith D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S234 - S234
12345